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ABSTRACT In cancer, multidrug resistance (MDR) is the simultaneous resistance of tumor cells to different natural product
anticancer drugs that have no common structure. This is an impediment to the successful treatment of many human cancers. A
common correlate of MDR is the overexpression of a membrane protein, P-glycoprotein. Many studies have shown that MDR
can be reversed after the use of substrate analogs, called MDR modulators. However, our understanding of MDR modulation is
incomplete. In this article, we examine the electrical properties of the human leukemic cells (K562) and its MDR counterpart
(K562AR) using dielectrophoresis and ﬂow cytometry (with a membrane potential sensitive dye, DIOC5), both before and after
treatment with XR9576 (a P-glycoprotein-speciﬁc MDR-reversal agent). The results show signiﬁcant differences in the
cytoplasmic conductivity between the cell lines themselves, but indicate no signiﬁcant changes after modulation therapy. We
conclude that the process of MDR modulation is not associated with changes in the electrical properties of cancer cells.
Moreover, the results demonstrate that using the ﬂow cytometry method alone, with MDR cells, may produce artifactual
results—whereas in combination with dielectrophoresis, the results show the role of MDR modulators in preventing drug efﬂux
in MDR cells.
INTRODUCTION
Malignant cancers are a major cause of morbidity in the
western world; they account for a quarter of all deaths. The
most common methods of treatment include local excision or
radiation, chemotherapy, immunotherapy, and biological-
response modiﬁers. Chemotherapy has been considered as
the most effective treatment for metastatic tumors. However,
drug resistance is a serious impediment to the successful
treatment of many human cancers and is responsible for
many tens of thousands of deaths each year. One form of
classical drug resistance is called multidrug resistance
(MDR), characterized by cross-resistance to many anti-
cancer drugs that have no common structure. A common
feature of MDR is the overexpression of membrane
glycoproteins, collectively termed as the ATP-binding-
cassette (ABC) transporters. The MDR1 gene product
P-glycoprotein (P-gp) pump has been postulated to cause
an increase in drug efﬂux, which gives rise to reduced and
ineffective intracellular drug concentrations.
It has long been recognized that membrane transport of
anticancer drugs can be blocked, with consequential reversal
of MDR, by the use of pharmacological agents termed
modulators or chemosensitizers. Modulation therapy is given
in combination with anticancer drugs, as was ﬁrst described
using in vitro cell line models (Biedler and Riehm, 1970;
Tsuruo et al., 1981), an approach subsequently used in many
clinical trials (Bell et al., 1985; Cowie et al., 1995). The ﬁrst-
generation MDR modulators such as verapamil and cyclo-
sporin A (CsA), proved disappointing due to side effects and
drug concentrations in the blood which were too low to bring
about MDR reversal (Pennock et al., 1991; Kerr et al., 1986).
The second-generation modulators (e.g., PSC-833) were
more potent than their predecessors, and less toxic. However,
PSC-833 has subsequently been shown to be a CNS toxin,
a substrate for P-gp, and regarded as a partial antagonist.
Third-generation modulators were developed to overcome
the limitations of second-generation modulators and have
been shown to speciﬁcally and potently inhibit P-gp
function. An example of a third-generation modulator is
the anthranilamide Tariquidar (XR9576; Xenova Ltd.,
Slough, UK), which has now reached phase III clinical trials.
Despite more than 25 years of research, the mechanisms
underlying MDR reversal have not been fully clariﬁed.
Recent data describing binding afﬁnity studies (Martin et al.,
1999) showed that XR9576 interacted with P-gp with
very high afﬁnity and potently inhibited its function. The
mechanism of action of XR9576 has been suggested to be
via noncompetitive interaction at sites that are allosterically
linked. P-gp can be considered as a multisite model with sites
that either function to transport cytotoxic drugs or mediate
inhibition of this process. Notwithstanding, there is a paucity
of data regarding the biophysical character of drug-sensitive
and -resistant cancer cells. An earlier study (Vayuvegula
et al., 1988) used a ﬂow cytometric-based assay with the
membrane potential sensitive dye DIOC5 to compare the
membrane potentials of drug-sensitive and MDR cancer cell
lines before and after treatment with verapamil and CsA. The
MDR cell lines were reported to have a lower membrane
potential compared with their corresponding drug-sensitive
parental cell lines. Subsequent incubation of the MDR cell
lines with CsA or verapamil appeared to restore membrane
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potentials to that of the parent cell lines. These data
suggested that alteration of membrane potential is a feature
of MDR cancer cells and that modulation therapy acts to
reverse this effect.
The AC-electrokinetic techniques such as dielectropho-
resis (DEP) and electrorotation have been described as the
motion of neutral matter caused by polarization in a non-
uniform ﬁeld (Pohl, 1978; Jones, 1995; Hughes, 2002). They
have been extensively used both as characterization and
separation techniques to study dielectric properties of both
the membrane and cytoplasm for a number of biological
particles (Wang et al., 1993, 1999; Washizu et al., 1994;
Markx et al., 1994; Stephens et al., 1996; Gascoyne et al.,
1997; Yang et al., 1999; Archer et al., 1999; Chan et al.,
2000; Arnold, 2001; Hughes et al., 2002). DEP and
electrorotation have also been employed both as an
investigative tool and as the basis of a diagnostic method
in cancer research (Hu et al., 1990; Burt et al., 1990;
Gascoyne et al., 1992, 1993, 1997; Becker et al., 1994;
Wang et al., 1997, 1999; Cristofanilli et al., 2002).
The study presented here has employed DEP to examine
the differences in dielectric properties between drug-
sensitive and MDR cancer cells before and after treatment
with the P-gp speciﬁc modulator, XR9576. DEP measure-
ments showed that the cytoplasmic conductivity of the
doxorubicin human leukemic resistant cell line (K562AR) is
signiﬁcantly higher than the drug-sensitive parent cell line
(K562), in the absence of any drug treatment. Subsequently,
treatment with the MDR modulator (XR9576) had no
signiﬁcant effects on the biophysical properties of either
cell line. In this article, we also demonstrate that by using
DEP in combination with ﬂow cytometry, modulating agents
(such as XR9576) do not alter the membrane potential of
MDR cells. Our data suggest that DIOC5 is a substrate for
the ABC transporter P-gp and that using this technique with
MDR cells gives rise to artifactual results.
MATERIALS AND METHODS
Chemicals and reagents
Doxorubicin (Sigma Aldrich, Poole, UK) was dissolved in sterile distilled
water and stored as frozen stock solution in aliquots, which were thawed
before use. XR9576 (kindly provided by Xenova Ltd., Slough, UK) was
dissolved in DMSO and stored as frozen stock solutions and were thawed
before use in experiments.
Cell culture
Human chronic myelogenous leukemia (K562) and its doxorubicin-resistant
counterpart (K562AR) were grown in modiﬁed RPMI-1640 medium
supplemented with 10% heat-inactivated fetal calf serum (FCS; Invitro-
gen, Paisley, UK), 2 mM L-glutamine, and 100 units mL1 penicillin-
streptomycin. All cell culture reagents were obtained from Sigma Aldrich
(Poole, UK), unless stated otherwise. Cell lines were cultured in a humidiﬁed
incubator with 5% CO2/95% air at 378C. K562AR was maintained in the
presence of 100 nM doxorubicin, which was removed for at least one
passage before use in experiments.
Conﬁrmation of MDR phenotype in K562AR
Chemosensitivity testing
The colorimetric assay using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), was performed, as described by Mosmann
(1983) to titrate cell viability after drug treatment. Leukemic cells at a density
of 1 3 105 cells mL1 in RPMI-1640 containing 10% FCS were dispensed
into 96-well plates in volumes of 200 mL and left to equilibrate for 24 h.
Freshly thawed drug solution was diluted in RPMI-1640 containing 10%
FCS and added in a volume of 50 mL in increasing concentrations. Control
wells containing cell suspension were supplemented with a similar volume
of medium. After 72 h incubation, cultured cells were treated with 20 mL of
5 mg/ml MTT in phosphate-buffered saline (PBS) solution (Sigma Aldrich,
UK) to each well. After 4 h of incubation, the plates were centrifuged at
200 3 g and the medium was removed. The tetrazolium crystals were
resuspended in 200 ml of DMSO. Absorbance was read at 540 nm using an
automated enzyme ELISA plate reader. The process was repeated when
using the XR9576 at 100 nM ﬁnal concentration. The results were expressed
as IC50, i.e., the concentration of cytotoxic drug that reduces cell viability by
50% relative to the control (untreated cells).
Western immuno-blotting
Crude cell membrane preparations were made using hypotonic lysis buffer
containing 1 mM PMSF, 1 mM NaVO4, aprotinin, leupeptin, and 150 mM
NaCl, in 10 mM Tris buffer (pH 7.4). The cells were left to lyse for 30 min,
sonicated, and then centrifuged for 10 min (Helena Biosciences, Sunderland,
UK) at 450 3 g, followed by a further centrifugation (Centrikon-T2060) of
60,0003 g at 48C. The ﬁnal pellet was resuspended in lysis buffer containing
0.2%SDS.The protein content of the lysateswas determined using amodiﬁed
Bradford protein assay (Bio-Rad Laboratories, Hemel Hempstead, UK).
50 mg of membrane protein was loaded onto a 10% acrylamide SDS and
resolved by SDS-PAGE. The presence of P-gp was detected with anti-P-gp
rabbit polyclonal antibody, H241 (Santa Cruz Biotechnology, Santa Cruz,
CA). Visualization was carried out using HRP conjugated secondary
antibody with chemiluminescence.
Cell preparation
Flow cytometry
The leukemic cell suspensions were resuspended in fresh 20 mM HEPES-
modiﬁed RPMI-1640 containing 10% FCS (both from Sigma, Aldrich, UK)
to obtain a cell density in the region of 106 mL1. The chemosensitizer
XR9576 was used at a ﬁnal concentration of 100 nM, as for chemosensitivity
testing. The membrane-potential-sensitive dye DIOC5 (3, 39- Dipentylox-
acarbocyanine iodide) was prepared, as a stock, in PBS and added to the cell
suspensions at a ﬁnal concentration of 10 mM. The dye was substituted with
media in control samples (with and without XR9576). After incubating at
378C for 30 min (with and without XR9576), membrane potentials were
recorded using a FACS analyzer (Becton Dickinson, Oxford, UK). Resting
membrane potentials from drug-sensitive cells were set on the ﬂuorescence
scale by adjusting the laser using the FL 1-PMT (525 nm) green ﬂuorescence
setting on the analyzer. The cells were gated on volume vs. scatter for
uniform size distribution. The membrane potentials were compared
according to the intensity of green ﬂuorescence emitted (assigned by the
parameter of geometric mean—GM—values). Thus, an increased membrane
potential is indicated by a higher ﬂuorescence intensity (i.e., higher GM
value), with the reverse being seen for lower membrane potentials.
Biophysics of Multidrug Resistance in Cancer 2029
Biophysical Journal 85(3) 2028–2034
DEP experiments
Drug-resistant and -sensitive cells (including those incubated for 30 min at
378C with XR9576) were centrifuged at room temperature at 0.19 3 g for
5 min. The pellets were washed and resuspended in isotonic medium
consisting of 8.5% (w/v) sucrose plus 0.3% (w/v) dextrose buffer (Gascoyne
et al., 1997). The sample conductivity was adjusted to 2.5 mS m1 using
PBS and the ﬁnal conductivity was veriﬁed with a conductivity meter (RS
Components, London, UK). The ﬁnal cell population was counted using
a hemocytometer and adjusted to ;3 3 105 cells per ml (615%) for DEP
measurements. To reduce the effect of variation in cell number in each
sample, the experiments were repeated many times (generally 4–6) with
different populations, which were summed before modeling.
As shown in Fig. 1, the system consisted of a signal generator, a light
microscope, and the dielectrophoresis chamber in which the cell
suspension was placed. The dielectrophoretic forces were generated by
two needle-shaped electrodes, pointing toward each other, with opposing
tips spaced 100 mm apart in a glass Petri dish. The needles were formed
by cutting a thin stainless steel rod at a shallow angle, such that cell
collection occurred along the sharpened edge. These edges were placed
facedown on the bottom of the chamber to ensure that cell collection
always occurred within the ﬁeld of focus of the microscope. The cell
suspension was added to the electrodes by micropipette. The electrodes
were energized by a Thurlby Thandar (Huntingdon, UK) signal generator
in the range 10–20 MHz at an applied voltage of 20 V (peak-to-peak).
Recordings were taken by exciting the electrodes for 1 min and counting
the collected cells using a handheld tally counter, as described by Pohl
(1978). The cell density was sufﬁciently low for the cell population to be
disperse enough for cell-to-cell interactions (pearl-chaining) not to affect
the results. Similarly, the cells were counted at arrival to the electrode
edge to ensure accuracy. The interelectrode gap was chosen to be
sufﬁciently large, and the time over which the experiment was performed
ensured that the volume over which cells were attracted to the electrodes
was sufﬁciently large, for variations in the local electric ﬁeld gradient due
to cell collection to have a minimal effect on the behavior of the cell
collection process. Measurements were taken at ﬁve frequencies per
decade, between 10 kHz and 20 MHz. Experiments were observed using
an inverted microscope (Carl Zeiss Group, Oberochen, Germany) and
charge-coupled device camera with videotaping for subsequent analysis.
The dielectric parameters for each cell line in the absence or presence of
XR9576 were obtained by ﬁtting the measurement spectra to the single
shell model (Irimajiri et al., 1979).
RESULTS
MDR conﬁrmation of P-gp
As illustrated in Table 1, the IC50 value (deﬁned as the
concentration of the drug that reduces cell viability by 50%
relative to untreated controls) for K562 was 0.58 mM (6
0.28) and 8.13 mM (6 1.18) respectively, indicating
a resistance of 14-fold. The treatment of K562AR cells with
doxorubicin in combination with the modulator XR9576
reduced the IC50 value to resemble that of the parent cell line
(0.48 mM 6 0.08 and 0.58 mM 6 0.28, respectively),
indicative of resistance reversal. Fig. 2 shows that the P-gp
(relative molar mass, Mr ¼ 170,000) is expressed highly in
the MDR cell line (K562AR), but is not detected in the
parental (K562) cells.
Flow cytometry
Membrane potentials of drug-sensitive and -resistant cancer
cells were assessed after 30 min exposure to the dye. As
shown in Fig. 3, a and b, the green ﬂuorescence intensity
emitted by the dye was markedly decreased in K562AR
(GM ¼ 36) relative to the K562 parental cell line (GM ¼
124). The modulator XR9576 did not have a noticeable effect
on the green ﬂuorescence intensity in K562, with GM values
unchanged after treatment with XR9576 (126). However, the
use of XR9576 with K562AR had a striking effect on the
ﬂuorescence intensity giving GM values of 492 relative to
124 for the parent K562 cell line.
DEP experiments
Fig. 4, a and b, show spectra of cell collection versus
frequency for K562 and K562AR respectively. The cells
were suspended in isotonic sucrose/dextrose medium with
FIGURE 1 A schematic diagram of DEP arrangement.
(1) TV and video screen; (2) microscope; (3) cells; (4)
electrodes, placed such that the tips are opposing; and (5)
signal generator.
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a conductivity of 2.5 mS m1. Both ﬁgures indicate that the
cells begin collecting after 10kHz in frequency. However,
the collection rate shows a decline above 2–3 MHz for K562,
unlike K562AR where the decline begins at 8–10 MHz.
Similar measurements were recorded for K562 and K562AR
after modulator treatment (not shown).
DISCUSSION
The dielectric parameters for both cell types were estimated
using a single-shell dielectric model (Huang et al., 1992) to
model the DEP response. The best ﬁt to experimental data
was found by scaling the polarizability by an arbitrary factor
to match the curve to the measured data, and then altering the
permittivity and conductivity of the membrane and cyto-
plasm until a best match was found. Similar methods have
been successfully used in the literature for the study of cells
(Burt et al., 1990), viruses (Hughes et al., 1998), and latex
beads (Bakewell and Morgan, 2001). The parameters
determined by this method are shown in Table 2. The
relative permittivity and conductivity of the medium were 78
and 2.5 mS m1, respectively. The cells were modeled as
being of diameters 8 mm and 8.6 mm for K562 and K562AR,
respectively. As mentioned in a previous study (Yang et al.,
1999), the use of a single-shell model represents an
approximation in the values obtained of the structurally
complicated cells; although a larger number of shells can be
used (e.g., Grifﬁth and Cooper, 1998), it is increasingly
difﬁcult to reliably determine a unique set of parameters. The
single-shell model can provide a useful method of
comparison of the differences in the dielectric properties of
the cell interior. Although this does not take into account
any differences in the ﬁne structure of the cell and any
implications this has for the derived dielectric data, it has
proven to be a useful tool for comparison of cells in a range
of contexts (Yang et al., 1999).
It can be seen from Table 2 that the drug-sensitive K562
appears to exhibit a lower cytoplasmic conductivity (0.23 S
m1) than its MDR counterpart K562AR (0.50 S m1),
before and after treatment with XR9576. This indicates
different ionic strengths in the cytoplasm of the parent cells
compared to MDR cells.
Despite the presence of P-gp, the DEP results indicate that
the electrical properties remained the same after treatment
with XR9576 in both K562 and K562AR cells. Also, there
do not appear to be any signiﬁcant differences in the mem-
brane conductivity or capacitance observed between cell
lines, implying no signiﬁcant morphological differences.
However, K562 exhibited a signiﬁcantly lower cytoplasmic
TABLE 1 A summary of the MTT-cytotoxicity results,
showing the IC50 values for K562 and K562AR using
doxorubicin and XR9576
Cell
line
Average IC50 with
doxorubicin mM (6 SD)
Average IC50 with doxorubicin
and XR 9576 mM (6 SD)
K562 0.58 (0.28) 0.35 (0.07)
K562AR 8.13 (1.18) 0.48 (0.08)
A summary of the MTT results (of at least three experiments), using
doxorubicin and XR9576 (100 nM) showing the IC50 values for each cell
line after 72 h incubation and of at least three experiments. The MDR
phenotype is further conﬁrmed in K562AR relative to K562, as the IC50
value increased from 0.58 mM to 8.13 mM, respectively. Key: AR,
Adriamycin(now known as doxorubicin)-resistant; SD, standard deviation.
FIGURE 2 A Western blot to demonstrate the expression of the MDR
protein (P-glycoprotein) in K562AR (right lane) and its absence in K562
(left lane), thus conﬁrming the MDR phenotype in K562AR.
FIGURE 3 A representative of at least four experiments showing ﬂow
cytometry results, using 10 mM DIOC5 in human leukemic cell lines. The
ﬁgure shows the differences in the green ﬂuorescence emitted by the
membrane-potential-sensitive dye DIOC5 for K562 (A) and K562AR (B)
before and after treatment with 100 nM XR9576. The ﬁlled graphs show
data recorded before treatment with XR9576, and the unﬁlled graphs show
data taken subsequent to treatment.
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conductivity than K562AR (0.23 S m1 vs. 0.50 S m1,
respectively) indicating a lower cell ionic content. Thus,
these data have discriminated the cell lines according to their
different dielectric properties. DEP has, therefore, brought
attention to differences in the cytoplasm, a part of the cell
that is not often considered in MDR.
By comparing the results obtained from DEP and ﬂow
cytometry, it can be seen that DEP results clearly do not
directly agree with those obtained by ﬂow cytometry.
However, examination of these differences can yield use-
ful information. The DEP results show that neither the
cytoplasmic or the membrane permittivities, or the conduc-
tivities, were altered in the presence of XR9576 for K562AR
(Table 2), despite P-gp expression. However, ﬂow cytometry
(Fig. 3, a and b), suggested an increase in membrane
potential after modulator treatment for K562AR. This con-
tradictory result may, we suggest, indicate that without the
modulator, the P-gp could be pumping DIOC5 dye out of the
cell, giving an artifactual result.
FIGURE 4 The average DEP collection spectrum for K562 and K562AR
of at least ﬁve experiments with the polarization model scaled to ﬁt. (A) DEP
collection spectra for K562, with collection starting from 10 kHz that starts
to decrease at ;3 MHz. (B) DEP collection spectra for K562AR showing
that the collection also starts at ;10 kHz but starts decreasing at ;8 MHz.
TABLE 2 A summary of the DEP results showing the electrical
parameters of both the cytoplasm and the membrane of K562
and K562AR before and after modulation with XR9576
Cytoplasm Membrane
Cell line s (S/m) e Ks (nS) Cspec (mF m
–2)
K562 0.23 (0.21–0.24) 40–80 0.008 8.2 (7.6–7.0)
K562AR 0.50 (0.48–0.51) 40–80 0.008 7.6 (6.3–8.8)
K562 1 XR9576 0.20 (0.19–0.21) 40–80 0.008 8.2 (7.6–8.8)
K562AR 1 XR9576 0.55 (0.51–0.58) 40–80 0.008 7.6 (6.3–8.8)
A summary of the DEP results, including the conductivity (s) and relative
permittivity (e) of both the cytoplasm and membrane for K562 and
K562AR before and after treatment with XR9576. The table shows the
increase in the cytoplasmic conductivity in K562AR relative to K562 (0.50
S/m and 0.23 S/m, respectively). Treatment with XR9576 caused no
changes in any of the biophysical parameters. It can be seen that there
appeared to be no changes taking place in the cytoplasmic permittivity or
the surface conductance (Ks). Key: AR, adriamycin (now known as
doxorubicin)-resistant; s, conductivity; e, permittivity; Ks, surface conduc-
tance; and C, capacitance.
FIGURE 5 An outline of the proposed mechanism of action of XR9576
using DEP and ﬂow cytometry. 1, A drug-sensitive cell, where DIOC5 dye
permeates the membrane, thus giving a high level of ﬂuorescence (indicative
of membrane potential); 2, a drug-resistant cell before XR9576 treat-
ment—DIOC5 permeates the membrane, but is then expelled from the cell
via P-glycoprotein, thus giving an artifactually low level of ﬂuorescence
(indicating low membrane potential); and 3, a drug-resistant cell subsequent
to XR9576 treatment, wherein XR9576 blocks P-glycoprotein and therefore
prevents DIOC5 from being expelled, thus giving rise to increased cellular
ﬂuorescence relative to 2 (i.e., increased, true membrane potential).
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We suggest that the contradictory results can be resolved if
XR9576 is considered to be blocking the P-gp pump and thus
preventing the efﬂux of the dye. In this regime, the ﬂuorescent
dye entering the membrane of the drug-resistant cells is
pumped out, resulting in an artiﬁcially low ﬂuorescence and
implied low membrane potential. When P-gp is blocked, this
pumping action does not occur and the high ﬂuorescence
level truly reﬂects the high cytoplasmic ionic strength. This
resolves the differences between the two results, and also
highlights the P-gp blocking effect of theXR9576 compound.
This mechanism of action is illustrated in Fig. 5. This ﬁnding
is in agreement with a previous study that suggested DIOC5
as being a substrate for ABC transporters (Gollapudi and
Gupta, 1992). It is also in agreement with the observation that
the DIOC5 result obtained for K562AR in the presence of
XR9576 was somewhat higher than that seen for the K562
parental line, indicative of a higher cytoplasmic conductivity.
There may be further effects on the cellular uptake of DIOC5
in the presence of XR9576 in K562AR cells that give rise to
this effect. In contrast, DEP did not reveal any signiﬁcant
differences in the electrical nature of the membranes of K562
and K562AR cells.
CONCLUSIONS
We have shown that DEP can be used as a technique to probe
the biophysical differences between cell lines, with MDR
cells exhibiting a higher cytoplasmic conductivity than the
parental cells. These data point to a difference in the relative
ionic content of the cells. XR9576, a P-gp speciﬁc modulator
did not exert any effects on the cytoplasm or membrane
parameters. Our data, therefore, show no signiﬁcant changes
in the biophysical properties of drug-sensitive or drug-
resistant cancer cells after modulation therapy. There has
been a disparity between DEP and ﬂow cytometry results.
DEP and ﬂow cytometry in combination indicated that
DIOC5 is a substrate for P-gp. Furthermore, DEP has
provided a more informative and a rigorous approach in
revealing that it is the cytoplasm that varies between MDR-
and drug-sensitive cells. The study has demonstrated the
application of DEP as a novel approach to aid a better
understanding of the MDR phenotype in cancer cells.
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